Pre-hospital oxygen therapy and saturation variability in COVID-19 patients with and without glucose metabolism disorders: part of the COLOS Study
The COVID-19 pandemic has revealed that viruses can have multiple receptor properties, penetrating various tissues and causing mutations in various genes, thus promoting a range of metabolic disorders. The purpose of this study was to investigate the connection between three factors: diabetic status, pre-hospitalization oxygen therapy, and saturation levels, to the values of morphological, inflammatory, and biochemical parameters in the blood serum of COVID-19 patients. The study group consisted of 2139 patients, 1076 women (50.30%) and 1063 men (49.70%), with an average age of 63.73 ± 15.69 years. The population was divided into three groups based on a three-stage scale, taking into account patients with either type 2 diabetes/prediabetes (473 patients), those who received oxygen therapy before hospitalization, and those with a saturation value of below 95% (cut-off value). Among patients who did not receive pre-hospitalization oxygen therapy, those with diabetes and a SpO2 level < 95% had significantly higher levels of D-dimers, procalcitonin, albumin, lymphocytes, RDW-SD ≥ 47, potassium, creatinine, and troponin T when compared to diabetic patients with a SpO2 level ≥ 95%. Similarly, in the same group of patients without pre-hospitalization oxygen therapy, those without diabetes but with a SpO2 level < 95% showed significantly increased levels of IL-6, CRP, albumin, lymphocytes, RDW-SD ≥ 47, glucose, potassium, sodium, creatinine, and ALT, compared to patients without diabetes and with a SpO2 level ≥ 95%. The findings suggest that lower saturation levels may result in increased potassium and glucose levels in patients who did not receive any oxygen therapy before hospitalization due to COVID-19. It is hypothesized that this may be caused by damage to pancreatic β-cells by SARS-CoV-2, and disturbances in the potassium channel, leading to cell membrane depolarization and insulin secretion.
Authors
- Agnieszka Bronowicka-Szydełko (ORCID: https://orcid.org/0000-0001-9967-036X)
- Agnieszka Matera-Witkiewicz (ORCID: https://orcid.org/0000-0002-1064-1237)
- Edwin Kuźnik (ORCID: https://orcid.org/0000-0003-3657-3970)
- Maciej Rabczyński (ORCID: https://orcid.org/0000-0001-5426-5475)
- Joanna Adamiec-Mroczek (ORCID: https://orcid.org/0000-0002-6804-358X)
- Małgorzata Trocha (ORCID: https://orcid.org/0000-0002-3951-205X)
- Janusz Sokołowski (ORCID: https://orcid.org/0000-0003-2992-5499)
- Paweł Lubieniecki (ORCID: https://orcid.org/0000-0002-5911-3902)
- Ewa A. Jankowska (ORCID: https://orcid.org/0000-0002-9202-432X)
- Krzysztof Kujawa (ORCID: https://orcid.org/0000-0003-2812-4702)
- Łukasz Lewandowski (ORCID: https://orcid.org/0000-0002-7624-631X)
- Katarzyna Madziarska (ORCID: https://orcid.org/0000-0002-3624-3691)
- Adrian Doroszko (ORCID: https://orcid.org/0000-0001-5472-028X)
- Marcin Madziarski (ORCID: https://orcid.org/0000-0003-2434-8725)
Institutions
- Wroclaw Medical University (PL)
Publication Details
- Journal
- Scientific Reports
- Published
- 2024-08-20
- DOI
- https://doi.org/10.1038/s41598-024-70240-w
- Citations
- 1
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39